Form 8-K - Current report:
SEC Accession No. 0000929638-24-002259
Filing Date
2024-06-25
Accepted
2024-06-25 16:05:16
Documents
13
Period of Report
2024-06-18
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 mei8k.htm   iXBRL 8-K 19738
  Complete submission text file 0000929638-24-002259.txt   154917

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA meip-20240618.xsd EX-101.SCH 3850
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20240618_lab.xml EX-101.LAB 21966
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20240618_pre.xml EX-101.PRE 16034
16 EXTRACTED XBRL INSTANCE DOCUMENT mei8k_htm.xml XML 4219
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41827 | Film No.: 241068934
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)